Jun. 1 at 7:31 PM
$XERS $ATYR
$XERS - A pretty safe investment into a slow but steady growing company. Their largest, TAM drug in their pipeline is LEVO, which could be their biggest asset yet, once their P3 trial starts in 2026 and probably ends in 2028, and after FDA approval. I estimate with steady growth, their SP can double to
$10 by 2027-2028. Then, if approved, LEVO hits. My goal for this stock is to sell at
$12-
$20 depending on the timeline, growth results and/or BO.
$ATYR - A high risk, high reward stock founded by Paul Schimmel. Schimmel has founded over 11 companies I believe, several whom have been BO and some which are still listed on the market, such as
$ALNY, which holds a market cap of 39.7B and a SP of
$306. Major P3 catalyst data readout set for Q3 2025. If results are good, analysts project a 4x-10x SP. Not to mention this stock is 70% institutionally owned, a rare feat for a tiny small cap biotech with no products on the market.
Just my opinions. Do your own DD. Good luck!
